Tapewire

Nasdaq · USD

AZTA

Azenta, Inc.

Export transactions ↓
Tapewire entity
4724
SEC CIK
0000933974
Parsed reports
596

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 08, 2025 Filed May 12, 2025 20:05 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 2,000 $27.67 $55,340.00
Disclosure

SEC source: 0000950170-25-069158 · ownership.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,513

F1 · shares: Open market purchase.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:05 UTC
Marotta JohnDirector · President and CEO
GrantCommon 3,637.638 $27.49 $99,998.67
Disclosure

SEC source: 0000950170-25-069157 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,658.135

F1 · shares: Open market purchase.

F2 · price: Represents the weighted average price for the shares purchased on May 8, 2025. The shares were purchased at per-share prices ranging from $27.31 to $27.97. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
May 08, 2025 Filed Jun 4, 2025 20:10 UTC Amendment
Marotta JohnDirector · President and CEO
GrantCommon 3,637.638 $27.49 $99,998.67
Disclosure

SEC source: 0000950170-25-081626 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,499.615

F1 · balance_after: The original Form 4, filed May 12, 2025, is being amended by this Form 4 Amendment solely to correct an administrative error. Following the 05/08/2025 acquisition of 3,637.638 shares, the Reporting Person's Amount of Securities Beneficially Owned was 104,499.615, not 102,658.135 as originally reported. Following the 05/09/2025 acquisition of 1,796.165 shares, the Amount of Securities Beneficially Owned was correctly reported as 106,295.780.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:10 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 2,200 $46.00 $101,200.00
Disclosure

SEC source: 0000950170-25-019885 · ownership.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,513

F1 · shares: Open market purchase.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:48 UTC GrantCommon Stock 4,040 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-011534 · tm256229-1_4seq1.xml · nonDerivative · entry 1

Koffey Quentin · CIK 0001984174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,035

F1 · shares: Annual grant of unrestricted shares under the Issuer's 2020 Equity Incentive Plan in connection with the Reporting Person's service on the Issuer's Board of Directors (the "Board"). The number of shares was determined based on an annual grant amount of $215,000 and a price per share of $52.32 based on the average daily closing price for the 20 trading-day period immediately preceding and including February 7, 2025.

F2 · price: No amount was paid upon grant of the shares.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC
Casal FrankDirector
GrantCommon 5,168 $52.32 $270,389.76
Disclosure

SEC source: 0000950170-25-017895 · ownership.xml · nonDerivative · entry 1

Casal Frank · CIK 0001891819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,560

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC
Malus Alan JDirector
GrantCommon 4,040 $52.32 $211,372.80
Disclosure

SEC source: 0000950170-25-017896 · ownership.xml · nonDerivative · entry 1

Malus Alan J · CIK 0001380163 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,035

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC GrantCommon 4,040 $52.32 $211,372.80
Disclosure

SEC source: 0000950170-25-017894 · ownership.xml · nonDerivative · entry 1

Davis Robyn C · CIK 0001580601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,627

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC GrantCommon 4,040 $52.32 $211,372.80
Disclosure

SEC source: 0000950170-25-017893 · ownership.xml · nonDerivative · entry 1

Nova Tina Susan · CIK 0001302605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,109

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC GrantRestricted Stock Unit · Derivative 4,040 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000950170-25-017898 · ownership.xml · derivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,040

Underlying: Common Stock · 4,040 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC
Doshi DipalDirector
GrantCommon 4,040 $52.32 $211,372.80
Disclosure

SEC source: 0000950170-25-017892 · ownership.xml · nonDerivative · entry 1

Doshi Dipal · CIK 0001613084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,040

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC GrantRestricted Stock Unit · Derivative 4,040 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000950170-25-017897 · ownership.xml · derivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,040

Underlying: Common Stock · 4,040 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:10 UTC GrantCommon 4,040 $52.32 $211,372.80
Disclosure

SEC source: 0000950170-25-017891 · ownership.xml · nonDerivative · entry 1

McLaughlin Erica · CIK 0001740348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,858

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 21:10 UTC
Hughes ViolettaVP, Chief Accounting Officer
SaleCommon 317 $52.97 $16,791.49
Disclosure

SEC source: 0000950170-25-013430 · ownership.xml · nonDerivative · entry 1

Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,603

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on January 31, 2025 of 894 restricted stock units held by the reporting person.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:10 UTC
Zhou GingerSVP and General Manager, Genom
PurchaseCommon 417 $45.88 $19,131.96
Disclosure

SEC source: 0000950170-25-013428 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,916

F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act

Read SEC document
December 05, 2024 Filed Dec 9, 2024 21:10 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 5,768 $45.00 $259,560.00
Disclosure

SEC source: 0000950170-24-134525 · ownership.xml · nonDerivative · entry 2

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,313

F1 · shares: Represents two grants of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan, one grant of 23,045 units subject to time-based vesting and will vest 33% per year for three years, beginning on December 5, 2025 and another grant of 5,768 units subject to time-based vesting and will vest 50% per year for two years, beginning on December 5, 2025. No amount was paid upon grant of the units.

Read SEC document
December 05, 2024 Filed Dec 9, 2024 21:10 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 23,045 $45.00 $1,037,025.00
Disclosure

SEC source: 0000950170-24-134525 · ownership.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,545

F1 · shares: Represents two grants of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan, one grant of 23,045 units subject to time-based vesting and will vest 33% per year for three years, beginning on December 5, 2025 and another grant of 5,768 units subject to time-based vesting and will vest 50% per year for two years, beginning on December 5, 2025. No amount was paid upon grant of the units.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 21:10 UTC
Wang David DongSVP & GM, SMS
Disposition to issuerCommon 140 $46.65 $6,531.00
Disclosure

SEC source: 0000950170-24-133678 · ownership.xml · nonDerivative · entry 1

Wang David Dong · CIK 0002000563 · SVP & GM, SMS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,974

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on December 2, 2024 of 470 restricted stock units held by the reporting person.

Read SEC document
November 19, 2024 Filed Nov 19, 2024 21:10 UTC
Marotta JohnDirector · President and CEO
PurchaseCommon 1,250 $40.67 $50,837.50
Disclosure

SEC source: 0000950170-24-128592 · ownership.xml · nonDerivative · entry 3

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,861.977

Read SEC document
November 19, 2024 Filed Nov 19, 2024 21:00 UTC PurchaseCommon 4,940 $40.77 $201,403.80
Disclosure

SEC source: 0000950170-24-128541 · ownership.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,405

F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $40.59 and $40.90. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:10 UTC
Cueto HermanEVP, Chief Financial Officer
SaleCommon 712 $40.07 $28,529.84
Disclosure

SEC source: 0000950170-24-129719 · ownership.xml · nonDerivative · entry 1

Cueto Herman · CIK 0001997198 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,892

F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,909 restricted stock units from one grant held by the reporting person and previously reported on Form 4.

F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:10 UTC
Pirogova OlgaSVP and CHRO
SaleCommon 548 $40.07 $21,958.36
Disclosure

SEC source: 0000950170-24-129724 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,373

F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,069 restricted stock units from one grant held by the reporting person and previously reported on Form 4.

F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:10 UTC
Hughes ViolettaVP, Chief Accounting Officer
SaleCommon 163 $40.07 $6,531.41
Disclosure

SEC source: 0000950170-24-129723 · ownership.xml · nonDerivative · entry 1

Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,920

F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 459 restricted stock units from one grant held by the reporting person and previously reported on Form 4.

F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:10 UTC
Zhou GingerSVP and General Manager, Genom
SaleCommon 491 $40.07 $19,674.37
Disclosure

SEC source: 0000950170-24-129722 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,499

F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,844 restricted stock units from three grants held by the reporting person and previously reported on Form 4.

F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:10 UTC
Wang David DongSVP & GM, SMS
SaleCommon 348 $40.07 $13,944.36
Disclosure

SEC source: 0000950170-24-129721 · ownership.xml · nonDerivative · entry 1

Wang David Dong · CIK 0002000563 · SVP & GM, SMS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,114

F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,069 restricted stock units from one grant held by the reporting person and previously reported on Form 4.

F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:10 UTC
Joseph JasonSVP, General Counsel, Secy.
SaleCommon 1,139 $40.07 $45,639.73
Disclosure

SEC source: 0000950170-24-129720 · ownership.xml · nonDerivative · entry 1

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,564

F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 3,638 restricted stock units from three grants held by the reporting person and previously reported on Form 4.

F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 18, 2024 Filed Nov 19, 2024 21:10 UTC
Marotta JohnDirector · President and CEO
PurchaseCommon 12,716.977 $39.48 $502,066.25
Disclosure

SEC source: 0000950170-24-128592 · ownership.xml · nonDerivative · entry 2

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,611.977

F2 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $39.35 to $39.51. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
November 18, 2024 Filed Nov 19, 2024 21:10 UTC PurchaseCommon 12,500 $39.60 $495,000.00
Disclosure

SEC source: 0000950170-24-128588 · ownership.xml · nonDerivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 14,755

F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $39.59 to $39.62. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

F2 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power.

Read SEC document
November 18, 2024 Filed Nov 19, 2024 21:10 UTC PurchaseCommon 1,000 $39.50 $39,500.00
Disclosure

SEC source: 0000950170-24-128589 · ownership.xml · nonDerivative · entry 1

HIRSCH DIDIER · CIK 0001226464 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,465

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:10 UTC
Marotta JohnDirector · President and CEO
GrantCommon 83,622 $41.51 $3,471,149.22
Disclosure

SEC source: 0000950170-24-128592 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,895

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:10 UTC
Pirogova OlgaSVP and CHRO
GrantCommon 10,381 $41.51 $430,915.31
Disclosure

SEC source: 0000950170-24-128593 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,921

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:10 UTC
Joseph JasonSVP, General Counsel, Secy.
GrantCommon 13,841 $41.51 $574,539.91
Disclosure

SEC source: 0000950170-24-128591 · ownership.xml · nonDerivative · entry 1

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,703

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:10 UTC
Hughes ViolettaVP, Chief Accounting Officer
GrantCommon 6,921 $41.51 $287,290.71
Disclosure

SEC source: 0000950170-24-128590 · ownership.xml · nonDerivative · entry 1

Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,083

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:10 UTC
Wang David DongSVP & GM, SMS
GrantCommon 8,651 $41.51 $359,103.01
Disclosure

SEC source: 0000950170-24-128587 · ownership.xml · nonDerivative · entry 1

Wang David Dong · CIK 0002000563 · SVP & GM, SMS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,462

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:10 UTC
Zhou GingerSVP and General Manager, Genom
GrantCommon 8,651 $41.51 $359,103.01
Disclosure

SEC source: 0000950170-24-128586 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,990

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:20 UTC Disposition to issuerCommon 995 $46.52 $46,287.40
Disclosure

SEC source: 0000950170-24-124120 · ownership.xml · nonDerivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,255

F1 · shares: Grant of unrestricted shares to the reporting person in connection with the reporting person's appointment to the Board of Directors. No amount was paid upon grant of the shares.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 13:19 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-115613 · tm2427880-1_4seq1.xml · nonDerivative · entry 1

Koffey Quentin · CIK 0001984174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 995

F1 · shares: Pro-rated annual grant of unrestricted shares under the Issuer's 2020 Equity Incentive Plan in connection with the Reporting Person joining the Issuer's Board of Directors (the "Board") on November 1, 2024. The number of shares was determined based on a pro-rated annual grant amount of $43,185 and a price per share of $43.41 based on the average daily closing price for the 20 trading-day period immediately preceding and including November 6, 2024.

F2 · price: No amount was paid upon grant of the shares.

Read SEC document
November 06, 2024 Filed Nov 14, 2024 21:27 UTC
Malus Alan JDirector
Disposition to issuerCommon 995 $46.52 $46,287.40
Disclosure

SEC source: 0000950170-24-127105 · ownership.xml · nonDerivative · entry 1

Malus Alan J · CIK 0001380163 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 995

F1 · shares: Grant of unrestricted shares to the reporting person in connection with the reporting person's appointment to the Board of Directors. No amount was paid upon grant of the shares.

Read SEC document
October 17, 2024 Filed Oct 21, 2024 20:10 UTC
Cueto HermanEVP, Chief Financial Officer
SaleCommon 1,595 $43.68 $69,669.60
Disclosure

SEC source: 0000950170-24-115940 · ownership.xml · nonDerivative · entry 1

Cueto Herman · CIK 0001997198 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,604

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on October 16, 2024 of 9,163 restricted stock units held by the reporting person.

Read SEC document
September 09, 2024 Filed Sep 11, 2024 20:10 UTC
Marotta JohnDirector · President and CEO
GrantCommon 3,273 $46.15 $151,048.95
Disclosure

SEC source: 0000950170-24-105506 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,273

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on September 9, 2025, 33% on September 9, 2026, and 33% on September 9, 2027.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 20:10 UTC
Cueto HermanEVP, Chief Financial Officer
GrantCommon 11,309 $55.27 $625,048.43
Disclosure

SEC source: 0000950170-24-096207 · ownership.xml · nonDerivative · entry 1

Cueto Herman · CIK 0001997198 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,199

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 20:10 UTC
Wang David DongSVP & GM, SMS
GrantCommon 6,333 $55.27 $350,024.91
Disclosure

SEC source: 0000950170-24-096206 · ownership.xml · nonDerivative · entry 1

Wang David Dong · CIK 0002000563 · SVP & GM, SMS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,811

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 20:10 UTC
Pirogova OlgaSVP and CHRO
GrantCommon 6,333 $55.27 $350,024.91
Disclosure

SEC source: 0000950170-24-096205 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,540

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 20:10 UTC
Joseph JasonSVP, General Counsel, Secy.
GrantCommon 10,856 $55.27 $600,011.12
Disclosure

SEC source: 0000950170-24-096203 · ownership.xml · nonDerivative · entry 1

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,862

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 20:10 UTC
Zhou GingerSVP and General Manager, Genom
GrantCommon 6,333 $55.27 $350,024.91
Disclosure

SEC source: 0000950170-24-096202 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,339

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 20:10 UTC
Joseph JasonSVP, General Counsel, Secy.
Disposition to issuerCommon 1,000 $62.05 $62,050.00
Disclosure

SEC source: 0000950170-24-089280 · ownership.xml · nonDerivative · entry 1

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,006

F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023.

Read SEC document
July 25, 2024 Filed Jul 29, 2024 20:05 UTC
Joseph JasonSVP, General Counsel, Secy.
Disposition to issuerCommon 3,000 $60.00 $180,000.00
Disclosure

SEC source: 0000950170-24-087278 · ownership.xml · nonDerivative · entry 1

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,006

F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:10 UTC
Hughes ViolettaVP, Chief Accounting Officer
Disposition to issuerCommon 584 $51.36 $29,994.24
Disclosure

SEC source: 0000950170-24-063492 · ownership.xml · nonDerivative · entry 1

Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,162

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:10 UTC
Joseph JasonSVP, General Counsel, Secy.
Disposition to issuerCommon 1,000 $60.15 $60,150.00
Disclosure

SEC source: 0000950170-24-040153 · ownership.xml · nonDerivative · entry 1

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,006

F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:10 UTC
Joseph JasonSVP, General Counsel, Secy.
Disposition to issuerCommon 4,000 $67.50 $270,000.00
Disclosure

SEC source: 0000950170-24-029238 · ownership.xml · nonDerivative · entry 4

Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,006

F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.